星昊医药
(430017)
| 流通市值：9.31亿 | | | 总市值：14.51亿 |
| 流通股本：7864.49万 | | | 总股本：1.23亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 358,429,374.32 | 375,926,324.75 | 312,056,719.94 | 365,433,610.45 |
| 结算备付金 | - | 0 | 0 | - |
| 拆出资金 | - | 0 | 0 | - |
| 衍生金融资产 | - | 0 | 0 | - |
| 应收票据及应收账款 | 84,763,555.68 | 110,117,515.72 | 93,960,933.11 | 99,711,102.39 |
| 其中：应收票据 | 7,857,798.87 | 17,857,861.55 | 14,653,697.89 | 13,882,527.63 |
| 应收账款 | 76,905,756.81 | 92,259,654.17 | 79,307,235.22 | 85,828,574.76 |
| 应收款项融资 | 771,606.27 | 6,118,938.52 | 5,181,125.05 | 4,456,730.6 |
| 预付款项 | 6,914,457.37 | 2,779,738.14 | 6,438,358.4 | 3,166,883.54 |
| 应收保费 | - | 0 | 0 | - |
| 应收分保账款 | - | 0 | 0 | - |
| 应收分保合同准备金 | - | 0 | 0 | - |
| 其他应收款合计 | 8,070,663.4 | 8,038,210.4 | 4,124,292.15 | 4,071,195.8 |
| 其中:应收利息 | - | 0 | 0 | - |
| 应收股利 | - | 0 | 0 | - |
| 买入返售金融资产 | - | 0 | 0 | - |
| 存货 | 68,115,898.47 | 60,591,812.03 | 76,910,335.73 | 77,183,159.98 |
| 合同资产 | - | 0 | 0 | - |
| 一年内到期的非流动资产 | - | 0 | 0 | - |
| 其他流动资产 | 2,737,329.94 | 1,455,155.48 | 5,909,609.79 | 6,181,300.88 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 936,613,056.69 | 936,380,215.59 | 937,183,731.51 | 970,264,039.89 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | 0 | - |
| 债权投资 | - | 0 | 0 | - |
| 其他债权投资 | - | 0 | 0 | - |
| 长期应收款 | - | 0 | 0 | - |
| 长期股权投资 | 8,254,042.05 | 8,410,266.32 | 8,409,198.45 | 8,582,540.2 |
| 其他权益工具投资 | 9,259,671.37 | 9,259,671.37 | 9,739,999.03 | 9,739,999.03 |
| 其他非流动金融资产 | - | 0 | 0 | - |
| 投资性房地产 | - | 0 | 0 | - |
| 固定资产 | 638,661,078.15 | 640,381,903.69 | 632,541,168.2 | 642,305,717.52 |
| 在建工程 | 26,541,719.85 | 25,486,347.34 | 38,983,916.87 | 32,914,151.11 |
| 生产性生物资产 | - | 0 | 0 | - |
| 油气资产 | - | 0 | 0 | - |
| 使用权资产 | - | 0 | 0 | - |
| 无形资产 | 59,567,320.72 | 39,712,795.16 | 42,221,376.99 | 43,055,783.03 |
| 开发支出 | - | 0 | 0 | - |
| 商誉 | - | 0 | 0 | - |
| 长期待摊费用 | 452,921.6 | 561,742.85 | 695,990.39 | 830,237.93 |
| 递延所得税资产 | 34,477,758.75 | 33,465,413.23 | 33,893,949.2 | 32,646,293.11 |
| 其他非流动资产 | 115,031,887.24 | 106,129,782.23 | 109,439,646.38 | 55,574,703.96 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 892,246,399.73 | 863,407,922.19 | 875,925,245.51 | 825,649,425.89 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,828,859,456.42 | 1,799,788,137.78 | 1,813,108,977.02 | 1,795,913,465.78 |
| 流动负债: | | | | |
| 短期借款 | 10,007,181.57 | 10,506,688.55 | 10,000,000 | 10,000,000 |
| 向中央银行借款 | - | 0 | 0 | - |
| 吸收存款及同业存放 | - | 0 | 0 | - |
| 拆入资金 | - | 0 | 0 | - |
| 交易性金融负债 | - | 0 | 0 | - |
| 衍生金融负债 | - | 0 | 0 | - |
| 应付票据及应付账款 | 52,790,473.29 | 41,247,533.03 | 89,444,130.94 | 53,950,789.64 |
| 其中：应付票据 | 8,044,750 | 5,572,260 | 13,713,797.23 | 9,601,537.23 |
| 应付账款 | 44,745,723.29 | 35,675,273.03 | 75,730,333.71 | 44,349,252.41 |
| 预收款项 | - | 0 | 0 | - |
| 合同负债 | 62,677,150.48 | 50,923,143.32 | 42,438,723.07 | 48,530,369.05 |
| 卖出回购金融资产款 | - | 0 | 0 | - |
| 应付手续费及佣金 | - | 0 | 0 | - |
| 应付职工薪酬 | 10,064,325.71 | 15,266,226.93 | 5,991,212.28 | 6,247,593.66 |
| 应交税费 | 10,410,437.99 | 14,556,120.85 | 10,169,777.62 | 6,357,335.46 |
| 其他应付款合计 | 48,689,067.1 | 46,139,938.65 | 31,684,700.4 | 36,304,603.28 |
| 其中:应付利息 | - | 0 | 0 | - |
| 应付股利 | - | 0 | 0 | - |
| 应付分保账款 | - | 0 | 0 | - |
| 保险合同准备金 | - | 0 | 0 | - |
| 代理买卖证券款 | - | 0 | 0 | - |
| 代理承销证券款 | - | 0 | 0 | - |
| 一年内到期的非流动负债 | - | 0 | 0 | - |
| 其他流动负债 | 9,580,936.71 | 16,321,760.57 | 10,026,760.02 | 13,384,061.93 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 204,219,572.85 | 194,961,411.9 | 199,755,304.33 | 174,774,753.02 |
| 非流动负债: | | | | |
| 长期借款 | - | 0 | 0 | - |
| 应付债券 | - | 0 | 0 | - |
| 优先股 | - | 0 | 0 | - |
| 永续债 | - | 0 | 0 | - |
| 租赁负债 | - | 0 | 0 | - |
| 长期应付款 | - | 0 | 0 | - |
| 长期应付职工薪酬 | - | 0 | 0 | - |
| 预计负债 | - | 0 | 0 | - |
| 递延收益 | 116,548,121.74 | 120,983,242.87 | 122,961,719.82 | 127,243,476.75 |
| 递延所得税负债 | 1,537,230.62 | 1,491,748.09 | 1,780,242.7 | 1,631,162.24 |
| 其他非流动负债 | - | 0 | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 118,085,352.36 | 122,474,990.96 | 124,741,962.52 | 128,874,638.99 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 322,304,925.21 | 317,436,402.86 | 324,497,266.85 | 303,649,392.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 122,577,200 | 122,577,200 | 122,577,200 | 122,577,200 |
| 其他权益工具 | - | 0 | 0 | - |
| 优先股 | - | 0 | 0 | - |
| 永续债 | - | 0 | 0 | - |
| 资本公积 | 713,346,683.96 | 713,346,683.96 | 716,975,957.18 | 716,975,957.18 |
| 减:库存股 | 18,219,402.81 | 18,219,402.81 | 23,000,000 | - |
| 其他综合收益 | -786,399.4 | -786,625.81 | -314,860.99 | -304,400.42 |
| 专项储备 | - | 0 | 0 | - |
| 盈余公积 | 44,223,186.94 | 44,223,186.94 | 40,631,430.14 | 40,631,430.14 |
| 一般风险准备 | - | 0 | 0 | - |
| 未分配利润 | 643,975,225.17 | 619,022,388.38 | 626,755,756.55 | 607,370,787.79 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,505,116,493.86 | 1,480,163,430.66 | 1,483,625,482.88 | 1,487,250,974.69 |
| 少数股东权益 | 1,438,037.35 | 2,188,304.26 | 4,986,227.29 | 5,013,099.08 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,506,554,531.21 | 1,482,351,734.92 | 1,488,611,710.17 | 1,492,264,073.77 |
| 负债和股东权益合计 | 1,828,859,456.42 | 1,799,788,137.78 | 1,813,108,977.02 | 1,795,913,465.78 |
| 公告日期 | 2024-04-26 | 2024-04-22 | 2023-10-20 | 2023-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |